Company Filing History:
Years Active: 2012-2015
Title: Jason Liou: Innovator in SGLT2 Inhibitor Processes
Introduction
Jason Liou is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of SGLT2 inhibitors. With a total of 2 patents, his work has the potential to impact the treatment of diabetes and related conditions.
Latest Patents
Liou's latest patents focus on innovative processes for the preparation of complexes that are useful in purifying compounds that inhibit the sodium-dependent glucose cotransporter SGLT. These processes are designed to reduce the number of steps required to obtain the target compounds, and the complexes formed are typically provided in a crystalline form. This advancement not only streamlines the production process but also enhances the purity of the final products.
Career Highlights
Throughout his career, Jason Liou has worked with notable companies such as Theracos, Inc. and Theracos Sub, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Liou has collaborated with talented individuals in his field, including Yuelin Wu and Shengbin Li. These partnerships have fostered an environment of innovation and have led to the successful development of his patented processes.
Conclusion
In summary, Jason Liou is an influential inventor whose work on SGLT2 inhibitors is paving the way for advancements in diabetes treatment. His contributions to the field are noteworthy and demonstrate the importance of innovation in pharmaceuticals.